MINDPAX and EVERSANA announce U.S. commercialization partnership

Mindpax is thrilled to announce recently developed collaboration with life sciences commercial services company EVERSANA.


EVERSANA is a leading provider of commercializing solutions for many health companies, including top 25 U.S. biopharma companies. The all-embracing agreement between Mindpax and EVERSANA covers U.S. market access, including FDI certification, market distribution and commercialization, growth acceleration, as well as patient onboarding. The partnership duration is agreed on eight years and advances MINDPAX in speeding up the neuroscience revolution.

EVERSANA Press Release
contact-us-background

Contact Us

If you are interested in our vision and thinking about getting involved yourself, your loved one or investing in a meaningful project do not hesitate to contact us.

Book a demo